Skip to content

Clinical trials

Brain Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Country / region: Belgium Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20143
20152
20163
20172
20181
20213
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed7
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
TauRx Therapeutics Ltd2
University Hospital of Mont-Godinne2
Xenon Pharmaceuticals Inc.2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
BBB-Therapeutics B.V.1
Bristol-Myers Squibb1
Eli Lilly and Company1
Genentech, Inc.1
KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases22
Central Nervous System Diseases12
Nervous System Diseases10
Alzheimer Disease7
Dementia6
Neurodegenerative Diseases6
Epilepsy4
Seizures4
Brain Neoplasms3
Central Nervous System Neoplasms3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.